Estados financieros detallados de Genprex, Inc. (GNPX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.41, GNPX presenta beneficios negativos (P/E no significativo) y un ROE del -163.13%. La capitalización bursátil es de $2M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | $5885 | $13070 | $22777 | $22534 | $25575 | $15004 | $6693 | 0 |
| Beneficio Bruto | 0 | 0 | -$5885 | -$13070 | -$22777 | -$22534 | -$25575 | -$15004 | -$6693 | 0 |
| I+D | $354883 | $289934 | $971427 | $2.0M | $7.3M | $9.0M | $11.5M | $17.6M | $10.5M | $9.4M |
| Generales y Administrativos | $3.8M | $3.0M | $11.4M | $8.7M | $10.6M | $11.7M | $12.3M | $13.4M | $10.6M | $6.1M |
| Gastos Operativos | $4.1M | $3.3M | $12.4M | $10.7M | $17.9M | $20.6M | $23.8M | $31.1M | $21.2M | $15.5M |
| Beneficio Operativo | -$4.1M | -$3.3M | -$12.4M | -$10.7M | -$18.0M | -$20.7M | -$23.8M | -$31.1M | -$21.2M | -$15.5M |
| EBITDA | -$4.1M | -$3.3M | -$12.3M | -$10.6M | -$17.9M | -$20.6M | -$23.7M | -$30.8M | -$21.1M | -$15.5M |
| Gastos por Intereses | 0 | $1890 | $37982 | 0 | 0 | 0 | 0 | 0 | 0 | $739935 |
| Beneficio Antes de Impuestos | -$4.1M | -$3.3M | -$12.4M | -$10.7M | -$17.9M | -$20.7M | -$23.7M | -$30.9M | -$21.1M | -$16.2M |
| Impuestos | 0 | $80 | $29184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$4.1M | -$3.3M | -$12.4M | -$10.7M | -$17.9M | -$20.7M | -$23.7M | -$30.9M | -$21.1M | -$16.2M |
| BPA | $-16830.00 | $-12705.00 | $-39567.00 | $-29304.00 | $-22198.00 | $-19305.00 | $-21780.00 | $-24838.00 | $-5872.98 | $-382.80 |
| BPA Diluido | $-16786.00 | $-12683.00 | $-39534.00 | $-29249.00 | $-22198.00 | $-19305.00 | $-21780.00 | $-24816.00 | $-5872.98 | $-382.80 |
| Acciones en Circulación (Diluidas) | $246 | $261 | $313 | $364 | $807 | $1070 | $1090 | $1243 | $3642 | $42397 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$3.3M | -$3.5M | -$4.5M | -$4.5M |
| EBITDA | -$3.3M | -$3.5M | -$4.5M | -$4.4M |
| Beneficio Neto | -$3.8M | -$3.8M | -$4.5M | -$4.4M |
| BPA | $-110.00 | $-25.30 | $-14.08 | $-9.40 |
| BPA Diluido | $-110.00 | $-25.30 | $-14.08 | $-9.40 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $1.6M | $161251 | $8.6M | $2.0M | $27.3M | $38.6M | $21.0M | $6.7M | $1.6M | $7.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $9297 | $655 | $127 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | $801780 | $3.0M | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $1.6M | $193574 | $8.8M | $3.0M | $30.7M | $39.1M | $21.5M | $7.5M | $2.1M | $8.4M |
| Inmovilizado Material | $5157 | $7804 | $24354 | $44654 | $39441 | $48608 | $23032 | $7859 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $241037 | $298569 | $379451 | $491200 | $601625 | $642360 | $702095 | $773478 | 0 | 0 |
| Activos Totales | $1.9M | $1.3M | $9.3M | $3.5M | $31.4M | $42.9M | $25.1M | $10.7M | $4.1M | $10.2M |
| Cuentas por Pagar | $109661 | $629074 | $295069 | $436258 | $192968 | $973195 | $442925 | $1.4M | $1.1M | $743070 |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $285661 | $830964 | $387821 | $510684 | $450724 | $1.6M | $2.8M | $3.3M | $2.5M | $2.2M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $285661 | $830964 | $387821 | $510684 | $450724 | $1.6M | $2.8M | $3.3M | $2.5M | $2.2M |
| Reservas | -$14.1M | -$17.5M | -$29.8M | -$40.5M | -$58.4M | -$79.1M | -$102.8M | -$133.7M | -$154.8M | -$171.0M |
| Patrimonio Neto | $1.6M | $428574 | $8.9M | $3.0M | $30.9M | $41.3M | $22.3M | $7.4M | $1.6M | $8.0M |
| Deuda Total | 0 | $201890 | $92750 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$1.6M | $40639 | -$8.5M | -$2.0M | -$27.3M | -$38.6M | -$21.0M | -$6.7M | -$1.6M | -$7.8M |
| Capital Circulante | $1.4M | -$637390 | $8.5M | $2.5M | $30.3M | $37.6M | $18.7M | $4.3M | -$426703 | $6.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $1.1M | $7.8M | $18.0M | $15.2M |
| Activos Totales | $3.6M | $10.2M | $20.3M | $17.1M |
| Pasivos Totales | $2.8M | $2.2M | $3.4M | $2.3M |
| Patrimonio Neto | $767807 | $8.0M | $16.9M | $14.8M |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$4.1M | -$3.3M | -$12.4M | -$10.7M | -$17.9M | -$19.6M | -$23.7M | -$30.9M | -$21.1M | -$16.2M |
| Amortizaciones | $862 | $3242 | $5885 | $13070 | $22777 | $22534 | $25575 | $15004 | $6693 | 0 |
| Compensación en Acciones | $2.7M | $1.3M | $5.4M | $3.5M | $4.2M | $5.3M | $4.7M | $5.4M | $3.3M | $312835 |
| Cambio en Capital Circulante | $225616 | -$184571 | $84538 | $192993 | -$261279 | $1.0M | $1.2M | $698126 | -$121078 | -$135026 |
| Flujo de Caja Operativo | -$1.2M | -$2.2M | -$6.8M | -$6.9M | -$13.9M | -$14.3M | -$17.8M | -$24.7M | -$17.1M | -$15.3M |
| Inversiones (CapEx) | -$89534 | -$63421 | -$103317 | -$946899 | -$2.3M | -$83796 | $4 | -$71383 | 0 | -$1 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$277.1M | 0 |
| Flujo de Caja Libre | -$1.3M | -$2.2M | -$6.9M | -$7.9M | -$16.3M | -$14.4M | -$17.8M | -$24.8M | -$17.1M | -$15.3M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$3.2M | -$4.1M | -$3.1M | -$5.1M |
| Inversiones (CapEx) | -$2 | $10 | -$3 | 0 |
| Flujo de Caja Libre | -$3.2M | -$4.1M | -$3.1M | -$5.1M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | 0 | $38689 | 0 | $68354 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | +19.8% | -273.3% | +13.9% | -68.4% | -15.2% | -14.9% | -30.0% | +31.6% | +23.1% |
| Crecimiento BPA (anual) | | +24.5% | -211.4% | +25.9% | +24.2% | +13.0% | -12.8% | -14.0% | +76.4% | +93.5% |
| Cambio en Acciones (anual) | | +6.1% | +19.9% | +16.3% | +121.7% | +32.6% | +1.9% | +14.0% | +193.0% | +1064.1% |
| Crecimiento FCF (anual) | | -67.1% | -211.0% | -13.2% | -106.9% | +11.7% | -23.7% | -39.5% | +30.9% | +10.7% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.2% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-5438.20 | $-8563.28 | $-22204.00 | $-21608.85 | $-20163.99 | $-13428.71 | $-16310.97 | $-19959.76 | $-4708.70 | $-361.14 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $76089.79 | $0.00 |
| Acciones en Circulación (Básicas) | $245 | $261 | $313 | $364 | $807 | $1070 | $1089 | $1243 | $3642 | $42397 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -163.13% |
| Rentabilidad sobre capital invertido | -107.08% |
| Rentabilidad sobre activos | -96.27% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 6.77 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -27.43 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -12.29 | -16.28 | -1.22 | -0.48 | -8.23 | -2.99 | -2.93 | -0.41 | -0.16 | -0.10 |
| P/VC | 31.18 | 125.94 | 1.71 | 1.70 | 4.77 | 1.49 | 3.12 | 1.70 | 2.11 | 0.21 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |